Stocks Prognosis
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site

AstraZeneca Faces Investigation Over China President's Conduct

Published on November 2, 2024
AstraZeneca PLC (NASDAQ:AZN) has come under scrutiny as its China President, Leon Wang, is being investigated for misconduct. The company's shares rose slightly but lagged behind the market. Investors are advised to stay informed about the investigation's progress and seek professional advice from Stocks Prognosis for accurate stock forecasts.
Go to AZN Page

Investor opinions & comments

To leave a comment, you need to Login or Register.

There are no comments yet. Be the first to leave one!

Other Data for AZN

ASTRAZENECA PLC Stock Hits QuantWave Forecast Target with 12.29% Profit

October 1, 2025

ASTRAZENECA PLC Stock Hits Price Target, Yielding 14.42% Profit for QuantWave Users

October 1, 2025

ASTRAZENECA PLC Stock Hits Price Target Forecast, Yielding 11.04% Profit

October 1, 2025

ASTRAZENECA PLC Hits QuantWave Forecast Target with 14.37% Profit

October 1, 2025

ASTRAZENECA PLC Hits Price Target Forecast with a Profit of 14.73%

October 1, 2025

ASTRAZENECA PLC Hits QuantWave Forecast, Generating 16.24% Profit

September 3, 2025

Related Data

AstraZeneca PLC Faces Investigation into China President Leon Wang

November 3, 2024

AstraZeneca's China President Under Investigation: What Investors Should Know

November 2, 2024

AstraZeneca Faces Investigation in China: Some Information for Investors

October 30, 2024

Investors Should Know: AstraZeneca AZN Rises, But Trails Market

November 4, 2024

AstraZeneca Faces Investigation by Chinese Authorities

December 12, 2024